INTRODUCTION
Hemophilus influenzae may be isolated with or without an amorphous polysaccharide capsule. All encapsulated strains belong to one of six serologic types (1) , whose distinguishing polysaccharides have been chemically characterized (2) (3) (4) infection caused by this species (5) . Meningitis, the most common of these, occurs predominantly in children 1-3 yr of age. Fothergill and Wright observed that in vitro bactericidal activity against a type b strain was seldom detectable in the blood of children in this age range but was generally present in neonates, older children, and adults, who very rarely have this disease (6) . Ward and Wright found that the type b bactericidal activity of fresh blood in vitro was due mainly to antibody and complement with only a slight activity being attributable to antibody-dependent phagocytosis (7). Fothergill and colleagues thus suggested that the critical factor in resistance is bactericidal antibody-acquired first transplacentally, then actively, with an intervening period of susceptibility. A role for antibody-enhanced phagocytosis in resistance, however, was suggested from the observation that serotherapy of meningitis apparently increased the extent of phagocytosis by leukocytes in the cerebrospinal fluid (8) . Thus, although opsonization of H. influenzae has not been systematically studied, the mechanism of specific immunity has come to be viewed as some combination of the complement-dependent bacteriolytic and the opsonic activities of antibody (8, 9) .
Wright and Ward observed that serum bactericidal activity against their type b strain was inhibited by its culture filtrate but not by the filtrate of an unencapsulated derivative of this strain, and they suggested that bactericidal antibody was directed against the capsule ("precipitinogen"). Antiserum to the unencapsulated derivative agglutinated the derivative and its encapsulated parent to an equal extent but was bactericidal only to the former (10) . Moreover, blood of children in the susceptible age range readily killed the derivative while failing to kill the parent strain (6) . These results suggested that anticapsular antibodies are the key to specific humoral immunity and that antibodies to somatic antigens are unimportant for host resistance. Such a conclusion was supported by Alexander' Strains b-62S-u, b-Madigan-u, and b-Rabinowitz-u are unencapsulated mutants that arose as nonmucoid sectors of colonies of their. respective parent strains. The mutants produce about 1/1000 the level of PRP of the parent strains as determined by hemagglutination-inhibition assays of culture supernatants or sonic extracts of cells. By this technique, which is sensitive to as little as 1/10,000 the level of PRP characteristic of type b strains, the untypable strain U-1 produces no detectable PRP.
Isolates of H. influienzae b vary greatly in the rate at which unencapsulated mutants occur in culture in vitro (14) . The encapsulation of strain b-Eagan is genetically very stable, and therefore it has been employed as an assay standard.
Cutltutre methods. Bacteria were grown at 37°C on BHI-DB medium (brain-heart infusion plus 1/1000 volume each of supplements D and B added after autoclaving.) Supple ployed. Unfixed human Rh-type G erythrocytes were washed three times in PBS and stored (up to 4 wk) in Alsever's solution at 4°C. For antigen sensitization the cells were suspended at 1.2% (v/v) in PBS containing 0.25 jug PRP/ml, incubated 1 hr at 37°C, washed three times to remove unabsorbed antigen, and suspended in PBS at 0.6%.
(The optimal PRP concentration was 0.125-0.5 ,ug/ml; higher concentrations slightly depressed titers. The binding of PRP to the cell surface was stable-sensitized cells could be stored at 4°C for at least 4 days without loss of sensitivity.) Serial twofold dilutions (25 ,ul) of test serum in PBS containing 0.25% bovine serum albumin were prepared in U-bottom microtiter trays (type TS-MRC-96; Linbro Chemical Co., New Haven, Conn.) with the use of microdroppers and microdiluters (Cooke Engineering Co., Alexandria, Va.), and 25-,ul drops of cell suspension were added. As a control for nonspecific agglutination, each serum was diluted in duplicate with one series receiving sensitized and the other unsensitized cells. The trays were sealed, thoroughly shaken, and incubated 3 hr at 37°C. Agglutination was read by tipping the tray to a vertical position and observing for several minutes: a pile of unaggregated cells flowed smoothly downward in a stream, whereas aggregated cells adhered to the bottom or fell together as a clump.
Cells from different type G, Rh-donors gave similar but not identical results; all assays reported below were thus done with cells from the same donor. In repeated assays the reciprocal titer of the standard human antiserum was always within one twofold dilution of 320. When cells fixed with glutaraldehyde (17) were substituted for unfixed cells, comparable titers were obtained with most sera. Many sera, however, were found to nonspecifically agglutinate the fixed cells (but not the unfixed cells obtained from the same donor).
Hemagglutination-inhibition assays for the detection of PRP were performed by adding 25-,ul drops of test solution or control solutions with known concentrations of purified PRP to 25-,ul serial dilutions of rabbit anti-H. influenzae b serum. These mixtures were incubated 30 min at 37°C, 25-,ul drops of PRP-sensitized cells were added, and the assay was completed as described above.
Serum bactericidal assay. Serial twofold dilutions (25 ,ul) of test serum were made in 1 ml microtiter trays (type 96 SC, Linbro Chemical Co.) held in an ice water bath; the diluent was PBS containing 5% bovine serum albumin, 0.5 mM MgSO4, and 0.15 mm CaC12. To each well was added a 25 ul drop of a mixture consisting of 11/20 diluent, 1/4 agammaglobulinemic serum, and 1/5 PBS suspension containing approximately 400 bacteria. The trays were closed, shaken, and incubated 1 hr at 37°C; 0.8 ml of agar (at 45°C) was then added with thorough mixing. After 18 hr of further incubation at 37°C, individual colonies were readily visible in the agar, and the end point was taken to be the highest dilution producing a reduction in colony count readily detectable by eye (about 50%).
Higher sensitivity bactericidal assay. Sera with undetectable or equivocal activity at 1/2 dilution in the regular bactericidal assay were tested as follows. The chilled culture was centrifuged (10 min at 10,000 g at 4°C), and the cell pellet was resuspended in PBS before dilution. Test sera were heated 30 min at 56°C to remove internal complement activity. A mixture of 90 ul serum and 10 ,l of PBS containing about 400 bacteria was incubated in a small, corked test tube for 1H hr at 28-30°C, and then chilled to 0°C. 15 ,ul of agammaglobulinemic serum was added, and after mixing, a 30 IAl sample was spread on agar to establish a 0 min count. The tubes were then incubated at 37°C, and samples were spread at 30 and 60 min. The coefficient of variation for colony counts was 12%. This technique of sampling was also used in calibration of the dilution assay and determining the kinetics of bactericidal activity.
Opsonization assay. A previously described spectrophotometric method (18) was calibrated for use with H. influenzae. The chilled bacteria were washed once in PBS and suspended in veronal buffer, pH 7.35, ionic strength 0.065 (19) to a concentration of 1.5 X 109 viable bacteria/ml. The final reaction mixtures consisted of 0.4 ml of 0.2% nitro blue tetrazolium, 2.5 X 106 peripheral blood phagocytes suspended in approximately 0.1 ml buffer, 0.1 ml of bacterial suspension, and the specified volume of fresh serum-with volumes being equalized with buffer. All components except the phagocytes were assembled at 4°C and incubated at 37°C for 10 min. Phagocytes were added, and the mixture was incubated at 37°C for 30 min. The reaction was stopped with HCl, and the phagocytized dye was extracted and quantitated as described (18) . Results of duplicate or triplicate assays for all test sera were averaged and expressed as A OD at 515 nm, a value obtained by subtracting the OD achieved by the phagocytosis of bacteria without serum (usually about 0.060) from that achieved in the presence of the test serum.
Inhibition of antibody activity by PRP. Sera were incubated 5 min at 370C and then 1 hr at 0°C with 1/100 volume of a 10 mg/ml solution of PRP. This procedure provided an excess of antigen without detectable anticomplementary effect.
Absorption of sera with the untypable strain U-1. The bacteria were grown to saturation in liquid medium, killed The antigen specificity of serum bactericidal activity to H. influenzae b
Whether PRP-directed antibody can be bactericidal was examined directly by comparing titers of an individual before and after immunization with purified PRP. (In the PRP-specific PHA assay the reciprocal titers of the pre-and postimmunization sera were < 2 and 320, respectively.) Table I shows that the preimmunization serum had generally low and variable activity against the eight tested b strains. Immunization with PRP elicited identical high titers to all eight; it did not, however, change the activity against a type a and a type c strain, a nontypable strain, and three PRP-deficient mutants of b strains. An identical specificity was demonstrated by preincubation of the anti-PRP serum with PRP: activity against b strains was reduced to preimmunization levels but that against other strains was not affected (Table I , last column).
Moderate activities against strains b-Rabinowitz and b-62S, however, were present before immunization and were not removed from the postimmunization serum by PRP. A direct indication that these activities were due to antibodies to non-PRP antigen(s) was provided by employing the untypable strain U-1, which makes no detectable PRP. Absorption with U-1 reduced the activity against b-Rabinowitz and b-62S from the preimmunization serum but did not reduce the titers of the postimmunization serum (Table II) .
The role of antibodies to PRP and non-PRP antigens in the type b bactericidal activity of normal sera was examined by preincubation with PRP (Table III) .
Bactericidal titers against strain b-Eagen were reduced fourfold or more by PRP in only 3 of 20 randomly selected sera. (These three had relatively high titers in the PRP-specific PHA assay.) Titers against bRabinowitz were not reduced, even in the sera of high PHA activity. The concentration of PRP employed was about 100-fold that necessary to inhibit completely the PHA activity of any of the tested sera. Thus the predominant bactericidal antibodies appeared to be non-PRP directed. Moreover, b-Eagan and b-Rabinowitz differed in susceptibility to these antibodies: titers against the two strains differed fourfold or more in about two-thirds of the sera.
14 of these 20 sera were absorbed with U-1 and then tested with or without PRP incubation against b-Rabinowitz. Three general patterns were discerned and are illustrated for three representative sera in Table IV: (a) U-1 reduced the activity, and the residual activity was inhibited by PRP-found in 8 of 14 sera; (b) U-1 completely removed the activity-found in 3 of 14; (c) U-1 partially removed the activity, and the residual activity was not inhibited by PRP-found in 3 of 14. Thus the bactericidal activity of normal sera may be The antigen specificity of opsonization Table V compares the effect of absorption with PRP on the opsonization activity of the anti-PRP serum and a normal serum representative of those in which bactericidal activity was not PRP inhibitable. The activity of the former was reduced nearly to its preimmunization value, while the latter was barely affected. It thus appears that opsonization of type b strains, like bactericidal activity, may stem from antibodies both to PRP and non-PRP antigens. different test organisms, and found no detectable bactericidal activity in the serum of 8 of 29 normal adults (21) . The present study found considerable variation among 114 normal adult sera in activity against strain b-Eagan (Fig. 1) ; all, however, were found to have at least some activity wlhen a sufficiently sensitive technique was applied. In a normal serum, the titer against strain b-Eagan often differed considerably from that against strain b-Rabinowitz (Table III) . Thus, the outcome of a population survey to ascertain the presence or absence of activity will depend not only upon the population studied but also upon the sensitivity of the assay technique and the type b strain employed. (8) . To explore whether this mechanism may have a role in active immunity, the opsonizing as well as bactericidal activities of human sera were studied. All of the 24 normal adult sera tested promoted the phagocytosis of strain b-Eagan to an extent much greater than the sera from three children with X-linked agammaglobulinemia. The opsonization activities of these sera correlated fairly well with their bactericidal titers against the same organism. The two systems, however, are not readily comparable in quantitative terms. In assays with some of the sera, the concentration of bactericidal antibody (and complement) was adequate to have killed the bacteria in the absence of phagocytes; with other sera, however, phagocytosis was promoted by concentrations of antibody insufficient for serum bactericidal activity. Antigenic experience indeed increases the ability of the serum to enhance phagocytosis of H. influenzae b in vitro, but the relative importance to human immunity of this mechanism and of the serum bacteriolytic reaction will be difficult to establish.
DISCUSSION
Any conclusion about the PRP specificity of type b bactericidal activity depends, of course, upon the antigenic purity of the material used for immunization or inhibition experiments. The preparation employed here appeared pure by the chemical and immunochemical criteria applied (15) . Immunization induced high bactericidal titers against all eight b strains tested but not against the untypable, a and c strains, nor the PRPdeficient mutants of three of the b strains (Table I ). The insensitivity of these mutants to the postimmunization serum is evidence against the possibility that the type b bactericidal antibody is actually induced by another type-specific antigen contaminating the PRP preparation. Were this the case, the contaminating antigen would, by coincidence, have to be lost from b strains in the same mutational event that produces the PRP deficiency. Thus, the increase in bactericidal titers by immunization and the inhibition of activity from some normal sera by the addition of PRP confirm the inference of Wright and Ward (10) that anticapsular antibody can sensitize type b strains to the bactericidal action of complement.
A substantial fraction of normal adult sera, however, had moderate type b bactericidal activity in the absence of detectable (PRP-specific) PHA activity (Fig. 1) . Moreover, preincubation with PRP under conditions eliminating PHA activity did not significantly reduce bactericidal activity in most of the 20 normal sera tested (Table III) . On the basis of these data alone it could be hypothesized that bactericidal activity not inhibited by PRP was due to low affinity anti-PRP antibodies not active in passive hemagglutination. In 11 of 14 tested sera, however, activity against strain b-Rabinowitz was reduced by absorption on the PRP-negative strain U-1. It thus appears that antigens of b strains other than PRP (and common to untypable strains) are also accessible to the bactericidal action of antibody and complement and that the corresponding antibodies are quite common in the normal adult population. The opsonization of b strains, like serum bactericidal activity can apparently be performed by antibodies both to PRP and non-PRP antigens. Antigens common to untypable and all encapsulated types of H. influenzae have indeed been isolated (13, 25, 26) , but their chemical identities and morphologic relationships are not well characterized.
Antigens of H. influenzae other than the type-specific polysaccharides are conventionally called somatic. The use of this term for the antigen(s) revealed in the present study should imply no particular structural arrangement. Mutation to PRP deficiency in two of the three b strains increased sensitivity to non-PRP-directed bactericidal antibody (compare b-Madigan with b-Madigan-u, etc.- Table I ). This result is consistent with the possibility of masking of the somatic antigens by PRP, but a more specific model is not warranted by the present data. Rabbit hyperimmune antiserum to intact cells of strain b-Eagan when reacted in gel diffusion with a sonic extract of b-Eagan gave only one faint precipitin line in addition to the major line formed with PRP. Conceivably, the finding of Alexander, Heidelberger, and Leidy that PRP absorption removed the protective power of rabbit anti-H. influenzae b antisera (12) stemmed from the inactivity of somatic antigens in the immunizing preparations.
Strains b-Eagan and b-Rabinowitz, although equally sensitive to the bactericidal action of anti-PRP antibody (Table I) , differed in susceptibility to the non-PRPinhibited antibodies in normal sera (Table III) . It would thus appear that the two strains differ in their content or arrangement of somatic antigens. Chandler, Fothergill, and Dingle observed that the unencapsulated mutants derived spontaneously from different type b strains were antigenically heterogeneous when examined by agglutination (14) . Conceivably some of the antigens responsible for such diversity are accessible to bactericidal antibody even while the PRP encapsulation is intact. Indeed, such a relationship has been demonstrated for the meningococcus: serum bactericidal activity to group C strains stems not only from antibodies to the group-specific polysaccharide capsule but also from antibodies to a number of other antigens heterogeneously distributed within the groups (27, 28) . One could speculate that bactericidal activity to a particular strain of H. influenzae b might arise from contact with an antigenically related untypable or non-b typable strain; the resulting activity, however, might not apply to a b strain of different antigenic structure. In contrast, the eight tested b strains were uniformly sensitive to the antibodies elicited by PRP (Table I) . Thus if serum bactericidal activity is critical for resistance to infection, anti-PRP antibody would presumably protect against any b strain.
